47
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
569740
Neurocentria is a clinical-stage pharmaceutical company.
- Guosong Liu: Chief Executive Officer & Founder
Fei Mao: Chief Chemist and Fonder
About the Company
Neurocentria is a clinical-stage pharmaceutical company founded with the mission to discover and develop treatments for neurological diseases, including cognitive impairment and neuropsychiatric disorders. Neurocentria's research has focused on synaptic function, the elemental unit of neuronal communication and whose dysfunction is a common
factor underlying both cognitive impairment and neuropsychiatric disorder. Two decades of research at Stanford, MIT, and Tsinghua University culminated in an understanding of the biology needed to restore synaptic function.
